Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology
Reference43 articles.
1. Bache RJ (1984) Can drugs really limit infarct size? In: Hearse DJ, Yellon DM (eds) Therapeutic approaches to myocardial infarct size limitation. Raven Press, New York, pp 185–208
2. Braunwald E, Kloner RA (1985) Myocardial reperfusion: A double-edged sword. J Clin Invest 76:1713–1719
3. Burton KP, Buja LM, Sen A (1986) Accumulation of arachidonate in triacylglycerols and unesterified fatty acids during ischemia and reflow in the isolated rat heart. Correlation with loss of contractile function and the development of calcium overload. Am J Pathol 124:238–245
4. Campbell WB, Johnson AR, Callahan KS, Graham RM (1981) Anti-platelet activity of betaadrenergic antagonists: Inhibition of thromboxane synthesis and platelet aggregation in patients receiving long-term propranolol treatment. The Lancet, December 19/26:1382–1384
5. Campbell CA, Przyklenk K, Kloner RA (1986) Infarct size reduction: A review of the clinical trials. J Clin Pharmacol 26:317–329
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献